Correction

Repligen adding former Motorola plant in MA to filtration footprint

By Dan Stanton contact

- Last updated on GMT

Repligen has leased a former Motorola faciility loacted at 111 Locke Drive, Marlborough, MA. GoogleStreetview
Repligen has leased a former Motorola faciility loacted at 111 Locke Drive, Marlborough, MA. GoogleStreetview

Related tags: 2016

Repligen has leased a 64,000 square-foot facility in Massachusetts to where it will transfer production of its TangenX filtration products .

Last week, Repligen Corporation leased a facility in Marlborough, Massachusetts for a period of 126 months, the details of which it submitted in an SEC filing​.

According to Sondra Newman, a spokesperson from the bioprocessing tools and equipment firm, the footprint expansion will incorporate its TangenX businesses, currently operating from a facility in Shrewsbury, Massachusetts.

Repligen bought TangenX Technology from French bioprocessing firm Novasep Holding in December 2016​ for €37m ($46m), adding single-use tangential flow filtration (TFF) cassettes to its downstream offering.

Regarding the new facility, Newman told this publication Repligen will take on the new space in stages, occupying about two-thirds of the site by the second half 2018, with room for further expansion over time.

“The initial plan for Marlborough is to house TangenX (flat sheet TFF) filtration operations and manufacturing,”​ she said, adding that while the firm will initially transfer employees from Shrewsbury and Worcester, the site will create new jobs over time, primarily technical and manufacturing jobs tied to increasing demand for the products we will manufacture in Marlborough.”

The site will eventually incorporate some of Spectrum's filtration products. Repligen bought Spectrum Pharmaceuticals for $350m in June 2017​, bolstering its portfolio with microfiltration and ultrafiltration-focused hollow fibre cartridges.

The former tenants at the 111 Locke Drive, Marlborough site was communications equipment firm Motorola.

Newman could not comment on the cost of refitting the site and adding equipment for now but Capex details will likely be disclosed during Repligen’s Q4 results call on February 22.

CORRECTION: The original article indicated Repligen was consolidating both TangenX and Spectrum into the new facility. While TangenX will fully move to Marlborough over time, only a 2,500 square-feet Spectrum plant in Worcester, Massachusetts will also be transferred. "Based on Spectrum Worcester’s close proximity, it makes sense to move this small operation into Marlborough as well,"​ Newman confirmed

Related news

Show more

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars